Myovant Sciences Ltd. Deferred Revenue
Myovant Sciences Ltd. had Deferred Revenue of $117.23 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-01-26
- 2022-12-31: Deferred Revenue, Current $117.23M.
- 2022-09-30: Deferred Revenue, Current $117.23M.
- 2022-06-30: Deferred Revenue, Current $100.56M.
- 2022-03-31: Deferred Revenue, Current $100.56M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-12-31 | $117.23M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $117.23M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $100.56M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $100.56M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $100.56M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $100.56M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $117.23M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $100.56M 10-K · filed 2022-05-11 |
| 2020-12-31 | $100.56M 10-Q · filed 2021-02-11 |
| 2020-03-31 | $40.00M 10-Q · filed 2021-02-11 |